On-Farm Experimentation to transform global agriculture.

Restructuring farmer-researcher relationships and addressing complexity and uncertainty through joint exploration are at the heart of On-Farm Experimentation (OFE). OFE describes new approaches to agricultural research and innovation that are embedded in real-world farm management, and reflects new demands for decentralized and inclusive research that bridges sources of knowledge and fosters open innovation. Here we propose that OFE research could help to transform agriculture globally.

The impact of the chronic disease assistance plan (CDAP) on the control of type 2 diabetes in Trinidad.

Objectives: (1) To measure the proportion of participants who used hypoglycaemic agents provided by CDAP only, for at least 6 months, and attained an HbA1c of
Design And Methods: The attainment of a glycosylated haemoglobin (HbA1c) concentration of View Article and Find Full Text PDF

What kind of rash is it?: deciphering the dermatologic toxicities of biologic and targeted therapies.

An overwhelming number of new agents, including targeted agents with unique mechanisms of action, are available in oncology practice today. Along with the benefit of new treatments for patients comes the unfamiliarity of associated toxicities and learning the best methods to minimize side effects. One such toxicity has been the spectrum of dermatologic reactions from some of the newer small-molecule inhibitors and monoclonal antibodies.

Molecular targets in cancer therapy.

Objectives: To review selected pharmacologic agents that target key cellular processes along with their mechanisms of action and adverse events. Nursing implications including what patients and families need to know, administration issues, and management of common toxicities will be reviewed.

Data Sources: Research articles, clinical trials, abstracts, and book chapters.